Wednesday, 11th November Clinical Oncology Society of Australia Annual Scientific Meeting 2026

For more information, visit the Breakfast Sessions page. 

Welcome by COSA President, Sabe Sabesan

Welcome to Country

Official opening by Tracey O’Brien

• Exploring the biomarker era, mechanisms of drug resistance, and the evolving landscape of precision oncology - Herbert Loong
• Optimising prescribing: Which adults with solid tumours benefit most from multi-gene pharmacogenomic panel testing? - Jessica Keen
• Thriving in The Long Middle - Beth Ivimey

This session includes a 15-minute panel discussion and will be joined by Tara Horrill. 

• Radiotherapy for Older patients  - Penny Mackenzie
• Frailty in Cancer: Moving from Identification to Intervention by Optimising Physical Function Across the Cancer Continuum - Germaine A Tan
• Fuelling Resilience: Nutrition's Role in Frailty - Elise Treleaven
• More than just age: Understanding frailty in people with cancer   - Elspeth Horwitz

This session includes a 30-minute panel discussion. 

This session includes a 10-minute introduction by Vivienne Milch. 

• You’re Not Too Young: Rethinking Early Detection in a Generation That Thinks It Has Time   - Hugo Toovey
• Identifying the aetiological drivers of early-onset colorectal cancer through the mapping of mutational processes - Daniel D Buchanan
• Diagnostic routes, intervals to treatment and perceived delays in diagnosis for early-onset vs older-onset colorectal cancer. - Rebecca J Bergin
• Bridging geography: a national virtual multidisciplinary team model for early-onset colorectal cancer - Prasad Cooray
• 15 years of Bowel Cancer Australia Specialist Support Services - Caring for People with Early-Onset Colorectal Cancer. - Fiona F Radford
• Pregnancy-associated cancer: an unexpected and devastating intersection - Sophie Boffa

• The gap is a chasm: first nation smoking - Maree Toombs
• Smoke, vapes and mirrors: New initiatives prompted by looking back - Freddy Sitas
• Vaping while smoking: the worst scenario - Becky Freeman
• Interventions and campaigns: is there an end? - Anita Dessaix

This session includes a 30-minute panel discussion and will be joined by Malinda Itchins and Cassandra Mazza. 

• Anticipatory anxiety in cancer screening: determining motivators and barriers - Tara Clinton-McHarg
• Cancer screening: How communication of breast cancer risk can affect women's anxiousness - Brooke Nickel
• Genetics: Anxiety and Inherited Disease Risk - Communicating about genetic risk - Rachel Williams
• In it together: Communication of fears and worries between survivors and their families   - Kyra Webb
• Precision Medicine, Persistent Uncertainty: Navigating Fear in Modern Cancer Care - Jia (Jenny) Liu

This session features a 30-minute panel discussion. 

• Working together with people with intellectual disability to advance equitable cervical cancer elimination: findings from the ScreenEQUAL clinical trial   - Sarah Simmonds and Deborah Bateson AM
• CanACTIVATE: Co-designing a national workforce development program to support the inclusion of exercise within cancer care. - Kate A Bolam
• The silent impact: educational and career disruptions among AYA with a parent or sibling facing cancer - Jennifer Cohen
• How does COSA’s ‘Roadmap to Reducing Financial Toxicity Experienced by People Affected by Cancer’ align with the Australian Cancer Plan? An expert-informed document analysis - Reegan Knowles
• A qualitative exploration of the perspectives and barriers to cancer clinical trial participation among Chinese speaking Australians - Alexander Li
• Evaluation of an online training module to address fear of cancer recurrence in clinical practice - Ben Smith

• Understanding patient experiences: Perceptions and Recall of Patients referred for Prostate Cancer treatment - Ella Cleary
• Inside the Trial: Patient experiences of innovation in minimally invasive thoracic surgery for lung cancer - Jennifer Donnelly
• Investigating effects of neuropsychological feedback on self-reported cognitive impairment in cancer survivors: A pilot randomised controlled trial - Heather J Green
• Mapping patient-reported measures to Australia’s Pan Cancer Core Outcome Set: recommendations for national alignment - Sandra Nolte
• The burden of menopausal vasomotor symptoms: results from a national survey of 2,000 Australian cancer survivors - Michelle Peate
• Changes in perceived cognitive functioning following a codesigned online group cognitive rehabilitation for prostate cancer survivors on androgen deprivation therapy: Series of single-case experimental designs - Haryana Dhillon
• Getting to the core of the matter: establishing Australia’s core outcome set for patient-reported measures in cancer - Imogen Ramsey
• "Someone Was Looking Out for Me": Patient Perspectives on What Makes Multimodal Prehabilitation Work - Kristy-Lee Raso
• Psychological Distress During Radiotherapy: Examining Trajectories and Predictors using a National Routine Screening Dataset of over 31,000 patients - Puma Sundaresan
• Geographic variation in symptoms at palliative care admission among Australian cancer patients - Jared Tang

• Supplements in Cancer Care: Separating Signal from Noise - Judith Lacey
• Building AI Health Literacy for the AI-health transformation: supporting safe, inclusive and equitable health outcomes - Kirsten McCaffery
• Nutrition Conversations in Cancer Care: Navigating Complexity, Evidence, and Patient Perspectives - Elizabeth Isenring
• The Gut Microbiome and Cancer Outcomes: Hype or Hope? - Craig Haifer

This session includes a 25-minute panel discussion and will be joined by Michael Ellies. 

• Age standardised incidence rate, risk factors, and outcomes of pregnancy associated cancer: a Queensland population data linkage study - Muyun (Sarah) Cao
• Real-world healthcare utilisation and costs in a lung cancer screening cohort: evidence from the Australian arm of the International Lung Screening Trial - David Goldsbury
• Ovarian cancer prognosis in women with a history of endometriosis: differences by endometriosis subtype - Amandi Hiyare Hewage
• The future burden of kidney cancer in Australian men and women preventable by modifying current behavioural risk factors: An international meta-analysis - Xinyi Qin
• Long-term projections of cancer prevalence in Australia to 2050: a population-based statistical modelling study - Qingwei Luo
• Trends in early-onset cancer incidence in Australia - Carolyn Nickson
• Ethnic and geographic variations in prostate cancer testing and incidence in New South Wales: A Population-based cohort study - Mijanur Rahman
• Lifestyle factors across generations and early-onset breast cancer risk: Evidence from the Australian Longitudinal Study on Women’s Health - Sohel Rana
• Variations in cancer incidence and stage by refugee status in New South Wales. - Siphiwe Ratladi
• The health economic case for expansion of liver cancer screening and surveillance in Australia - Eleonora Feletto

• Breast density and its impact on screening - Carolyn Nickson
• Screening and the elimination of cervical cancer in Australia - Megan Smith
• Making lung cancer screening a reality: the essential role of Primary Care - Vivienne Milch
• Psychological impact of cancer screening  - Rachael H Dodd

This session includes a 10-minute panel discussion. 

• Making sense: how to ensure clarity and understanding when explaining pharmacogenomic information to patients? - Jessica Keen
• Documentation of infusion-related reactions to systemic anti-cancer therapy: Development of a COSA Position Statement - Jessica Donnelly
• Personalised Dosing of Cancer Medicines in Clinical Practice - Ganessan Kichenadasse
• Postcode Shouldn’t Decide Care: Access to Cancer Medicines in Rural Australia - Katie Foy

• Prehabilitation in cancer care: an evidence update and implications for practice - Matthew P Wallen
• What Matters Most: Consumer‑Clinician Priorities in Prehabilitation - Christina Prickett
• Prehabilitation in Practice: Barriers, Enablers, and Real-World Implementation - Kristy-Lee Raso
• Value-based prehabilitation models of care - Haitham Tuffaha
• Embedding Prehab: What We've Learned & Where We're Heading - Daniel Steffens

This session includes a panel discussion. 

• 10 year survival outcomes following early feeding via a prophylactic gastrostomy – a randomised controlled trial in patients with head and neck cancer - Teresa Brown
• Mental Health Constructs and Tools in Exercise Oncology: A Systematic Review and Meta-Analysis - Jamie Chong
• Phase 2 trial of the PD-1/VEGF bispecific antibody, PF-08634404 (SSGJ-707), plus chemotherapy (chemo) in advanced NSCLC: updated results  - Malinda Itchins
• Self-reported cognitive and educational impacts among survivors of child, adolescent and young adult cancer - Ursula M Sansom-Daly
• Quality of life and fitness outcomes from the CCTG CO.21/CHALLENGE trial: structured exercise after adjuvant chemotherapy for colon cancer - Janette L Vardy
• Pretreatment Cardio-Oncology Risk Score (PCORS): Development and Internal Validation in Treatment-Naïve Breast Cancer   - Zechang Xin

• Rurality as an independent driver of cancer mortality: a systematic review and meta-analysis with implications for Australian cancer equity - Skye Marshall
• Variations in cancer incidence and stage by migration status in New South Wales. - Siphiwe Ratladi
• From Opportunistic Testing to Initiated Discussion: Developing Australia's 2026 Guidelines for the Early Detection of Prostate Cancer - David P Smith
• Polygenic risk scores enhance prostate cancer risk stratification: development and external validation of 5-year risk prediction models in UK and Australian cohorts - Julia Steinberg
• The Change in Profile and Systemic Therapy Exposure of Cancer Survivors in New South Wales (2005-2019): A Population-Based Study - Monica Tang
• Burden of reconstructive surgery for head and neck cancer: impact on health utility, quality of life, function, and work productivity - Rebecca L Venchiarutti

This session includes a 30-minute panel discussion. 

• Resource-Constrained Health Systems Innovation for Health Equity – How Indian Oncology is redefining value in cancer care - Satya Palanki
• Delivering common sense oncology care in our region and beyond - Deme Karikios
• Scaling Tele-Oncology for Equitable Cancer Care: From North Queensland to the Pacific - Shiv Pathmanathan

• Development and Characterisation of Iron Oxide Nanoparticles and a Three-Dimensional Glioblastoma Spheroid Model for Preclinical Chemoradiotherapy Research - Fatemeh Abhari
• A Place-Based Network Model to Strengthen Regional Cancer Research Capacity and Translation - Nikola Bowden
• A Multimodal Approach to Early Detection of Postpartum Breast Cancer Using Breast Milk: Mouse Models, Organoids, and Human Samples - Muyun (Sarah) Cao
• The LAMp-LC Study: Unveiling the lung microbiome in Australians with early- and late-stage lung cancer - Bryan A Chan
• Return-to-Work for Cancer Survivors in the Australian Life Insurance Context: A Multi-Stakeholder Qualitative Study - June Khaw
• MT2 Enhances Paclitaxel-Mediated Antitumor Efficacy Across Distinct Cancer Models - Km Cheng
• Dietary whey hydrolysate and medium-chain triglycerides contribution to optimising methotrexate treatment outcomes in Dark Agouti mammary adenocarcinoma - Ifeoma Dikeocha
• The contribution of nurses to palliative care clinical research investigator teams: A qualitative study  - Belinda Fazekas
• Selectivity and Pharmacokinetic Optimization of 7-Aminoquinazolines as Potent CSF1R Kinase Inhibitors for Human Triple-negative Breast Cancer Treatment - Hsing-Pang Hsieh
• “When you know better, you do better.” A Qualitative Exploration of Facilitators and Barriers of Adherence Among Breast Cancer Survivors Participating in a Telehealth Lifestyle Intervention - Shaun Kirsten
• Tumor Collagen-targeted T-cell therapy for sarcoma: The source of tumor collagen, mechanism of reduction, preclinical study, and early peek of clinical trial result - Shulin Li
• Ionizable Lipids Discovery Enable Functional mRNA Delivery for Clinical Translation of mRNA Vaccines - Wen-Shan Li
• Complications in Needle Prostate Biopsy: A Systematic Literature Review  - William Moore
• A window into the unknown: novel mass spectrometry methods to profile tumour effusion proteomes for cytokine detection and chemotherapy response prediction - Jack Scanlan
• Development and implementation of patient-reported outcome measures online training in Western Sydney Local Health District Cancer Services - Puma Sundaresan
• Analysing the cytotoxic effects of plant-derived compounds from wasabi and liquorice root and their interactions with docetaxel on prostate cancer cells. - Samuel Sii
• Biomarker landscape in gastro-entero-pancreatic neuroendocrine tumours: from chromogranin A to multi-omic panels - Sachpreet Singh
• Repurposing drugs and natural compounds to enhance the cytotoxic efficacy of doxorubicin on breast cancer cells. - Montana Vassallo
• Assessing Value for Money in Theranostic Nuclear Medicine: A Systematic Review and a Meta-analysis - Yufan Wang
• EpCAM Drives TNF-α-Induced Anaplastic Thyroid Cancer Progression Through Activation of the ERK-EGR1 Signaling Axis - Han-Chung Wu
• Comparable Local Control but Model-Dependent Abscopal Responses After FLASH and Conventional Radiotherapy in Tumors With Contrasting Immunogenicity - Tosol Yu
• Intratumoral Methylobacterium promotes papillary thyroid carcinoma cell  progression via BCAT2-dependent activation of the PI3K/Akt/mTOR signaling pathway. - Qin Zheng
• Total body photography for the diagnosis of cutaneous melanoma in adults: updated systematic review and meta-analysis    - Shannon Baker
• Co-designing a reduced-dose digital mental health intervention with, and for, people with cancer: Finding My Way – Micro - Liberty A Barry
• Utilisation of intramuscular and intermuscular fat to develop a new skeletal muscle grading score which can predict treatment outcomes for locally advanced rectal cancer. - Alex Besson
• Body composition changes during neoadjuvant treatment for locally advanced rectal cancer predicts pathological tumour response. - Alex Besson
• Impact of body mass index on Clinicopathological profile in breast cancer: Tunisian cohort study - Mohamed Bourhil
• Real‑world effectiveness of neoadjuvant pembrolizumab in triple‑negative breast cancer: a retrospective case series from the Salah Azaïez Institute, Tunisia - Mohamed Bourhil
• Does tumour budding predict prognosis in patients with gasto-oesophageal adenocarcinoma? A systematic review and meta-analysis - Dominic Bullock
• Impact of proton pump inhibitors on survival outcomes and immune-related adverse events in patients receiving immunotherapy: a single centre experience - Ji-In Chung
• Nutrition Impact Symptoms and Nutrition Outcomes in Patients with Pancreatic and Hepatobiliary Cancers During and After Treatment: A Systematic Review and Meta-Analysis. - Kate Connell
• Sustained remission and long-term survival outcomes with dostarlimab plus chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial (Encore) - Melissa MJ Farnham
• A review of five-year outcomes using Oncotype-DX guided adjuvant treatment in HR-positive early breast cancer – single site experience. - Lachlan Fitzpatrick
• Real-World Outcomes of First-Line Systemic Therapy for Metastatic Renal Cell Carcinoma Across Northern Sydney: A Multicentre Retrospective Cohort Study - Vaishnavi Anu Ganapathy
• Fungating testicular germ cell tumours: Case report and narrative review of clinical presentation and management strategies   - Daniel Sergio Garcia
• Multimodality treatment of EBV-positive oligometastatic nasopharyngeal carcinoma with maintenance toripalimab: a real-world case study - Thomas Hansen
• First-line PF-08634404 (SSGJ-707), a PD-1/VEGF bispecific antibody, + chemotherapy for advanced/recurrent endometrial cancer (EC) - Michelle Harrison
• Advancing Equity in Clinical Trials: Integrating a Sponsor-Initiated Decentralised Methodology Statement into Protocols - Francis Hinds
• Clinical Symbiosis: Treating Patient Centricity and Study Success as Co-Primary Priorities in Oncology Research - Francis Hinds
• Virtual Delivery of Supervised Physical Fitness Assessments for Childhood Cancer Survivors: A Feasibility Study - Chrissie Ho
• PROpatient: A registry-based randomised controlled trial of symptom monitoring, using patient-reported outcome measures and centralised care coordination, to improve quality of life in patients with upper gastrointestinal cancers. - Liane J Ioannou
• Friend or foe? Impact of concomitant medications on survival outcomes in patients receiving immune checkpoint inhibitors   - Maia Ismail
• Oral paclitaxel(DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer:a single-center exploratory analysis of the OPTIMAL phase III study - Lei Jiang
• Factors influencing use of magnetic resonance imaging in newly diagnosed advanced lung cancer patients: A single centre retrospective review - Tianjian Jiang
• Perineural invasion in gastroesophageal cancer: impact on clinical outcomes - Raphel Jomaah
• Differentiating functional and sleep-related factors of reduced health utility after head and neck free-flap reconstruction - Frances Kan
• Reduction in costs with a 4-week course of moderately hypofractionation chemoradiation in unresectable stage 3 non-small cell lung cancer: a secondary analysis from the phase 2 MODERN-LUNG trial - Mahesh Kumar
• Impact of Medicare Funding on Dihydropyrimidine Dehydrogenase Testing in Oncology Practice - Neil Kim Chiu Lam
• Rethinking lymphoedema prophylaxis after groin dissection for melanoma - Teresa S Lee
• A prospective study investigating the utility of sentinel lymph node biopsy (SLNB) in early-stage node-negative (cT1N0) Merkel Cell Carcinoma (BIOPSY-ME) - Ryan W Lim
• Diagnostic Challenges in Immune Checkpoint Inhibitor-Mediated Triple M Syndrome: A case highlighting diagnostic uncertainty.  - Jonathan Loh
• Clinical effectiveness of low fixed-dose rasburicase for prophylaxis and treatment of tumour lysis syndrome in patients with haematologic malignancies  - Taylor Mackie
• Exploring Background Factors and Diagnostic Pathways in Colorectal Cancer   - Meghana Maddula
• Exploring longitudinal changes in and relationships between nutrition impact symptoms, muscle mass and malnutrition following oesophagogastric cancer surgery. - Lisa Murnane
• Objective response to fecal microbiota transplantation plus immune checkpoint inhibition differs by prior immune checkpoint inhibitor exposure: A meta-analysis. - Shreya Parmar
• Systemic Therapy After Trabectedin in Advanced L-Sarcomas: Treatment Patterns and Outcomes From the Multicentre SEPSaC-01 Cohort - Agnieszka Pietruszka
• Complete responses to first-line pembrolizumab plus chemotherapy in PD-L1-positive advanced triple-negative breast cancer: a CEBCC-101 analysis - Agnieszka Pietruszka
• Immune-related Adverse Events in Neoadjuvant Triple Negative Breast Cancer Treatment: A single centre, retrospective cohort - Benjamin Rao
• Patient selection for primary cytoreduction or neoadjuvant chemotherapy in the treatment of ovarian cancer over time - Tanya Ross
• Exploring The Fidelity of Resistance Training Interventions in Regional, Rural, And Remote Cancer Care: A Systematic Scoping Review - Christopher Rowe
• Delivering Resistance Training to People with Cancer in Regional, Rural, and Remote Australia: A Qualitative Study of Exercise Professional’s Perspectives - Christopher Rowe
• Successful treatment of refractory Immune Thrombocytopenia with a combination of amifostine, rituximab and romiplostim: A case report  - Marissa Ryan
• Real-World EGFR Tyrosine Kinase Inhibitor Outcomes in Advanced NSCLC: A Single-Centre Audit With Focus on Elderly Patients - Ahmed Shouman
• Reverse cardio-oncology in hematologic malignancies: hypoxic, inflammatory, and clonal pathways linking cardiovascular disease and cancer - Sachpreet Singh
• Healthcare navigation burden and patient delay drive advanced-stage head and neck cancer presentation in northern india - Sachpreet Singh
• Long‑term overall survival follow-up of toripalimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma - Paul Smart
• Does exercise improve survival after a cancer diagnosis? A living systematic review and meta-analysis of randomised controlled trials - Rosa R Spence
• Management of oligometastatic cervical cancer: a review of the literature to inform clinical practice guideline development - Dana Stefanovic
• Incidence, Extent, and Management of Hypomagnesemia in Colorectal Cancer Patients During Epidermal Growth Factor Receptor Inhibitor (EGFRI) and Fluorouracil (5FU) Based Therapy at Ipswich Hospital: A Retrospective Audit - Lesley Dawson
• Fear of cancer recurrence in people attending the Sydney Cancer Survivorship Centre clinic (SCSC) - Sim Yee (Cindy) Tan
• A retrospective analysis of Selective InternalRadiation Therapy (SIRT) and chemotherapyfor metastatic pancreatic adenocarcinoma - Sue Thang
• Incidence and clinicopathological characteristics of very young onset, young onset and late onset colorectal cancer in a culturally and linguistically diverse Sydney population - Alexandra Thoms
• Malnutrition risk is independently associated with hospitalisation in early-phase oncology trial participants: a retrospective cohort study - Stephanie Vassallo
• Population-level impact of the COVID-19 pandemic on radiotherapy utilisation and fractionation for breast and lung cancer in NSW - Shalini K Vinod
• Does timing matter? A retrospective review of immune checkpoint inhibitor administration and cancer treatment response - Madeleine Washbourne
• Incidence of febrile neutropenia and time to count recovery in AML patients receiving pegylated G-CSF following HiDAC consolidation - Michael Whordley
• Association between dietary patterns and cardiometabolic health markers in overweight or obese men treated with androgen deprivation therapy: a cross-sectional analysis of the TelEX trial - Hattie H Wright
• Preliminary efficacy of the ‘RecoverEsupport Breast’ digital health intervention to enhance recovery in women undergoing surgery for breast cancer - Rebecca Wyse
• CIFeR Advanced - Adapting a clinician led intervention to address fear of cancer progression across advanced malignancies - Howard Yu
• Clinicopathological study of cervical lymph node metastasis in patients with oral tongue squamous cell carcinoma with pT1-2 - Jie Yu
• Association between C-reactive protein-albumin-lymphocyte index and overall survival in surgery patients with oral squamous cell carcinoma - Jie Yu
• Outcome prediction model impact on clinician confidence and treatment recommendations in older patients with head and neck cancer treated with radiotherapy - Farhannah Aly
• Precision requires visibility: Building the data foundation for equitable metastatic breast cancer care - Vicki Durston
• Dual-Strategy ctDNA MRD Assessment Improves Detection Sensitivity Across Diverse Early Breast Cancer Cohorts - Joachim Fluhrer
• Intra-tumoural manganese is associated with radioresistance and survival in glioblastoma (AO 02.25) - Gerald B Fogarty
• Cost-utility of BRCA and homologous recombination deficiency testing-guided treatments in ovarian cancer - Karitika Kashyap
• Implementing automated dashboards to drive equity in colonoscopy access and quality: a metro-regional collaboration - Diana Lewis
• Cost-utility of UDP-glucuronosyltransferase 1A1 (UGT1A1) deficiency testing-guided irinotecan treatment in pancreatic cancer - Kayleigh Mackenzie
• TrialCatch.org - An AI assisted clinical trial matching platform for oncologists in Australia and New Zealand. - Samuel R Miller
• Towards precision supportive care: A risk-stratified model to predict and address physical decline during chemotherapy - Lisa E Parry
• Pharmacological interventions to support cancer treatment in patients with a Serious Mental Illness: Preliminary results from a scoping review  - Lachlan Roth
• A learning cancer system for precision care: integrating clinical, population and patient-reported data across NSW - Shelley Rushton
• Cancer pharmacy standards for the precision generation: Update of the Advanced Pharmacy Australia (AdPha) Oncology and Haematology Standards of Practice - Marissa Ryan
• Advancing erectile dysfunction care after prostate cancer treatments: outcomes from an international multidisciplinary consensus building workshop - Sarah Weller
• Driving NLCSP implementation: a network strategy for health service readiness and earlier detection of lung cancer  - Linda Nolte
• Pre-emptive DPYD Genotyping-Guided Fluoropyrimidine Treatment in Solid Tumours: A Real-World Cost-Utility Analysis - Valerie Sutanta
• From Isotopes to Impact: Stakeholder Perspectives on the Access to Theranostic Radiopharmaceuticals - Yufan Wang
• The Role of Consumer Engagement in Improving Breast Density Policy, Practice and Research   - Helena Rodi
• Tailoring a primary care-based cancer clinical trial for the Chinese community - Yuhang Zhang
• Early-onset, female-predominant adenoid cystic carcinoma in an Omani population: clinicopathological features and patterns of failure - Abdallah Al Alawi
•  Dyspnoea-related distress in an Australian palliative care population with lung cancer. - Jill Chen
• Patterns of PSA testing in Australian men aged 70 years and older - Karen Chiam
• Obesity, metformin prescription and risk of advanced prostate cancer in non-diabetic men: findings from the 45 and Up Study - Karen Chiam
• Self-reported cancer-related behaviours by social proximity to a recent cancer diagnosis - Daniel G Coro
• Patient characteristics and treatment patterns of patients with advanced NSCLC harboring MET exon 14 (METex14) skipping enrolled in MOMENT disease registry - Stephanie Gasking
• De novo and acquired MET amplification in patients with non-small cell lung cancer (NSCLC) treated with tepotinib: Results from a real-world data analysis in Australia - Stephanie Gasking
• Contemporary epidemiology and real-world management of hepatocellular carcinoma (HCC) in Australia: insights from a prospective Australian national clinical quality registry - Liane Ioannou
• Potential risk factors associated with early-onset cancers: rapid review - Carolyn Nickson
• AllClear-RWE: Real-world evidence on early breast cancer treatment and outcomes ─ Baseline characteristics of a population-based cohort study, NSW, Australia, 2005-2019     - Sol Libesman
• Projections of incidence and mortality for head and neck cancer by clinically relevant groups in Australia to 2044 - Qingwei Luo
• Secondary Primary Cancers Among Childhood Cancer Survivors: A Population-Based Study using the Australian Childhood Cancer Registry  - Louise Marquart-Wilson
• Allostatic load and comorbidities in people with and without cancer: an analysis of the National Health and Nutrition Examination Surveys 2015-2023 - Bogda Koczwara
• Trends in risk factor exposure in relation to trends in early-onset cancers in Australia - Carolyn Nickson
• Sleep quality, physical activity and health-related quality of life in a population of individuals undergoing surveillance for colorectal cancer. - Ann Peter
• Association between risk-related lifestyle factors, screening adherence and breast cancer incidence: A decomposition analysis - Sohel Rana
• Breast cancer recurrence in contemporary population-based studies: a systematic review and meta‑analysis of local, regional, locoregional and distant outcomes - Meghan Stephensen
• Prognostic factors for prostate cancer in patients on active surveillance: a scoping review protocol - Chifeng Tan
• Impact of travel distance and time on treatment and outcomes for oral cavity cancer in NSW and ACT: a population-based data linkage study - Rebecca L Venchiarutti
• Visceral fat deposition among survivors of pediatric acute lymphoblastic leukemia - Carmen L Wilson
• 30-year trends in Gastric and Oesophageal Cancer in NSW: incidence, survival and mortality 1992-2022 - Georgette Wood
• Immunotherapy for locally advanced cervical cancer: a systematic review to inform Australia’s first Cervical Cancer Management Guidelines. - Susan Yuill
• Post-treatment nutrition interventions for childhood cancer survivors - Susannah K Ayre
• The effect of dietary interventions on cancer survival: A living systematic review and meta-analysis of randomised controlled trials - Brooke P Baker
• A health economic evaluation of Finding My Way-Advanced, a self-guided digital mental health intervention for women with metastatic breast cancer. - Lisa Beatty
• Treatment experiences, preferences, and information needs among Australians living with metastatic breast cancer: results from a national survey - Fran Boyle
• “I would have felt less lost”: Evaluating the LGBTQI+ People and Cancer resource     - Jenni Bruce
• The McGrath Model of Care and the Living Well framework - Vanessa N Brunelli
• Understanding unmet supportive care needs in regional paediatric oncology: Insights from children with cancer, their parents, and multidisciplinary health and community service professionals. - Jamie Bryant
• Beyond toxicity: A nurse practitioner-led immunotherapy supportive care clinic in a regional cancer centre - Danielle Burge
• Ruxolitinib for the treatment of CAR-T-related, corticosteroid-refractory ICANS: a single-centre case series  - Rachel Cathcart
• The CanHEAL Program: Advancing equity in cancer-related lymphoedema care for people from culturally and linguistically diverse backgrounds.  - Ashfaq Chauhan
• Clonidine as an Adjuvant for Opioid-Induced Hyperalgesia in Advanced Cancer Pain: A Case Report and Mechanisms. - Katarzyna Chmiel
• Hydromorphone-Induced Delirium in a Patient with Advanced Cancer: A Case Report - Katarzyna Chmiel
• Lost Opportunities, Lasting Costs: Financial impacts and future support needs of Adolescents and Young Adults impacted by Cancer - Jennifer Cohen
• Food, Movement, Sleep, and Social Patterns among People with Cancer and Their Carers in Supported Accommodation - Daniel G Coro
• Enhancing supportive care through a telehealth nurse-led survivorship clinic - Seleena Sherwell
• Title: Navigating the Psychosocial Journey: A Meta-Ethnographic Review of the Psychosocial Needs and Experiences of Children and Adolescents (0–19 Years) Diagnosed With Cancer Across the Care Continuum - Alyssa J Ebert
• Evaluating a new skin-care product in the prevention of radiation-induced skin reaction for patients - Vanessa Evans
• Mapping survivorship care across Victoria: Findings from a statewide environmental scan to inform equitable scale-up - Frezsa Fulia
• Enabling Rapid Implementation of Survivorship Models of Care Through the VICS Survivorship Grants Program - Frezsa Fulia
• Scaling Survivorship Care Across Victoria: Early Impact of the VICS Statewide Survivorship Program - Frezsa Fulia
• Indirect calorimetry in oncology - Kate Furness
• Measuring Financial Burden: Rural–Metropolitan Disparities in Breast Cancer Costs and a Novel Diagnostic Cost Methodology - Stewart Harper
• Living Loudly, Leading to the End:  Letters, lyrics  and legacy; A Young Man’s 10 L’s of Living and Dying on His Own Terms - Tarnya Hotchkin
• Glioma carers- Assessment of Individual Needs and Support  [The GAINS study]: Feasibility, preliminary effects, and Health Care Professionals perspectives of a nurse-led supportive intervention for carers of people with high-grade glioma - Matthew P Wallen
• “I’m here too!”: Exploring cancer survivorship experiences, needs, and preferences of people with intellectual disability and health professionals - Emma Kemp
• Effectiveness of Nurse-Led Frailty Screening in Improving Treatment Outcomes for Older Adults with Cancer: A Systematic Review - Stewart Harper
• Prioritising nutrition support needs in upper gastrointestinal cancer: A co-designed Delphi approach to resource development - Melanie Regan
• Living longer, living differently: Supportive care needs of people with lung cancer and family members - Yibai Li
• The multimorbid cancer survivor: a case report - Lynn Lim
• Mapping the Use of Isometric Exercise for Individuals Diagnosed with Cancer: A Scoping Review - Jeffrey Lin
• Circulating cell-free DNA dynamics in endometrial cancer, health, and exercise - Eliza R Macdonald
• The effect of health behaviour interventions on alcohol consumption among people living with cancer: a systematic review - Manuela Malaguti Beaty
• Risk perception and appraisal among women at increased risk of breast cancer: a scoping review of qualitative research - Chloe Maxwell-Smith
• Strategies to Optimise Outcomes in Risk Reducing Prophylactic Mastectomy and the Role of Psycho-Oncology and Behavioural Support - Chloe Maxwell-Smith
• Who gets counted? International researchers' perspectives on barriers to engaging adolescent and young adult cancer survivors in psychosocial research - Fiona EJ McDonald
• Structured Exercise, Physical Activity, and Fear of Cancer Recurrence Among Cancer Survivors: A Systematic Review - David Mizrahi
• Vaccinations in patients with solid organ malignancies  - Tahlia Molinaro
• Exercise engagement in adults with haematological malignancies: A qualitative systematic review - Melanie Moore
• Stronger bodies, stronger bonds: a culturally adapted wellbeing and social connectedness program for Chinese speaking cancer survivors. - James Murray
• Psychosocial guidelines and associated needs and evidence gaps - Carolyn Nickson
• Relationships between quality of life, bone pain, fatigue and disease symptoms, and physical activity, neuromuscular strength and fitness, in people with multiple myeloma - Jennifer L Nicol
• Contemporary Nutrition Care Practices and Outcomes in Patients with Head and Neck Cancer Undergoing Radiotherapy A Decade After Implementation of an Evidence-Based Model of Care - Amy OHalloran
• The acceptability of ‘RecoverEsupport’ - a digital health intervention to enhance recovery after colorectal cancer surgery: A mixed-methods evaluation within a randomised controlled trial   - Anna Palazzi-Parsons
• Pregnancy and Postpartum Associated Cancers: Translating Lived Experience into National Priorities for Earlier Diagnosis and Better Care - Rachelle Panitz
• Finding their place: Consumer leadership in cancer care - Pauline Ryan
• Associations between patient satisfaction with cancer care and selected health-related quality-of-life outcomes during systemic therapy - Agnieszka Pietruszka
• Can we move beyond disease-based referral triggers and use patient-reported needs to guide earlier palliative care integration?  - Melanie Rabbets
• Surviving cancer is not enough: a low-budget case study for sector consensus and national awareness - Sarah Stewart
• Does adding therapist guidance to Finding My Way-Advanced improve engagement and outcomes in women with metastatic breast cancer? A feasibility pilot. - Amy Rigg
• More than a waiting space: addressing the increasing demand for support services in a cancer wellbeing centre - Phoebe Rizzoli
• A multilevel theoretical framework for distress trajectories in brain tumour populations   - Julia L Robertson
• Digital traces of psychological distress in an online brain tumour support community: a computational linguistic analysis - Julia L Robertson
• Financial toxicity in advanced and metastatic cancer: a qualitative scoping review of patient, caregiver and clinician perspectives. - Ashleigh R Sharman
• The financial impact of metastatic breast cancer: insights from a qualitative study in the Australian context. - Ashleigh R Sharman
• Distress trajectories and geographic inequities during radiotherapy: Analysis of nationally collected routine distress scr - Puma Sundaresan
• Reducing the burden of chemotherapy-induced peripheral neuropathy (CIPN): A meta-analysis of exercise interventions - Dhiaan Sidhu
• Integrating coordinated informal care into supportive, patient-centred cancer care - Lauren Smith
• Impact of Early Integrated Palliative Care on Patient-Reported Outcomes in Patients with Lung Cancer: A Systematic Review - Aastha Srivastava
• Benchmarking Peripheral Neuropathy and Hypersensitivity Reactions in Paclitaxel-Treated Cancer Patients. - Jane J Stidworthy
• Diagnostic Performance of Current Screening Tools in Identifying Low Muscle Mass in Adults with Cancer: A Scoping Review - Natalie LX Tan
• Unmet supportive care needs and quality of life in people with head and neck cancer in Australia: a scoping review - Rex KY Tin
• From Isolation to Connection: Consumer-Informed Online Peer Support for People Affected by Head and Neck Cancer - Simon van der Stap
• Co-designing prostate-specific patient-reported outcome measures to support person-centred adaptation of the NSW Patient Reported Measures Program - Carolyn Mazariego
• Evaluating patient involvement in cancer multidisciplinary meetings: A systematic review - Selina Yang
• Oral Baclofen for Refractory Central Neuropathic Pain in a Patient with Cancer: A Case Report - Olly Zekry
•  Symbiotic-Lung-10: a phase 2 trial of PD-1/VEGF bispecific antibody, PF-08634404, as monotherapy or in combination for non-small cell lung cancer  - Surein Arulananda
• A phase 1/2 study of mRNA-2808 in participants with relapsed or refractory multiple myeloma - Claire L Borg
• A phase 2/3 trial of a PD-1/VEGF bispecific antibody (PF-08634404) in combination with chemotherapy in first-line for extensive-stage small cell lung cancer (ES-SCLC; Symbiotic-Lung-04)  - Bryan Chan
• Overcoming tumor penetration barriers via dual EGFR/TGF-β inhibition: A multicenter, randomized, double-blind, phase 2/3 study of ficerafusp alfa (BCA101) or placebo with pembrolizumab in first-line recurrent or metastatic (R/M) PD-L1-positive, HPV-negative head and neck squamous cell carcinoma (HNSCC): The FORTIFI-HN01 study - Marcin Dzienis
• Assessing the feasibility and tolerability of bright light therapy for the prevention of delirium in hospitalised adults with advanced cancer: protocol for a pilot RCT - Layla Edwards
• From the Ward to the Community: An Active Approach to Childhood Cancer (The MERRIER Study) - Chrissie Ho
• Symbiotic-Lung-01: a phase 3 trial of a PD-1/VEGF bispecific antibody, PF-08634404, vs pembrolizumab in combination with platinum-based chemotherapy in first-line for locally advanced or metastatic non-small cell lung cancer - Malinda Itchins
• Bridge2Health: Building capacity to navigate the Australian cancer health care system for culturally and linguistically diverse cancer patients - Alexia Koutoulas
• Developing a nurse-led Baduanjin programme for personalized cancer survivorship care: a cross-cultural mixed-methods study of nurses’ readiness, cultural competence, and implementation needs (trial in progress) - Wei-Hsiang Lin
• Establishing the first Victorian regional CAR T-Cell therapy service and a specialised nurse project lead at Barwon Health - Tanya Hendry
• Pilot group therapy for people diagnosed with stage III melanoma – the MELGROUP study - Kelly Nunes-Zlotkowski
• Trial in Progress: A mixed method cost-consequence analysis of the impacts of Decentralised Clinical Trial delivery in early phase oncology trials. - Anuradha Pala
• Evaluation of Current CIPN Screening and Management Practices: A National Survey - Susanna B Park
• Developing a Precision Supportive Care Pathway: Prospective Validation of Behavioural and Physical Function Risk Stratification During Chemotherapy (PACER Study) - Lisa E Parry
• Fit4CAR-T: Protocol for a Telehealth Exercise Prehabilitation Feasibility Study in Adults Undergoing Chimeric Antigen Receptor T-Cell Therapy for Lymphoma - Erica P Patterson
• Feasibility testing of telehealth-delivered exercise therapy for ostomates treated for cancer (FOXTROT) - Danielle J Pegg
• Symbiotic-Lung-14: a phase 2 trial of PD-1/VEGF bispecific antibody, PF-08634404, plus chemotherapy in 1L transformed small-cell lung cancer (t-SCLC)  - Rachel Roberts-Thomson
• Pilot Study Evaluating Ginger and Vitamin B6 for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderate- to High-Emetogenic Risk Regimens in an Oncology Day Unit   - Guru Sule
• Addressing information and support needs for people diagnosed with rare and less common cancers - Tamsin Farrugia